Works matching IS 03682811 AND DT 2018 AND VI 48 AND IP 12


Results: 17
    1

    Thanking All Peer Reviewers.

    Published in:
    Japanese Journal of Clinical Oncology, 2018, v. 48, n. 12, p. 1031, doi. 10.1093/jjco/hyy169
    Publication type:
    Article
    2
    3

    Randomized phase III study to evaluate the value of omission of prophylactic neck dissection for stage I/II tongue cancer: Japan Clinical Oncology Group study (JCOG1601, RESPOND).

    Published in:
    Japanese Journal of Clinical Oncology, 2018, v. 48, n. 12, p. 1105, doi. 10.1093/jjco/hyy125
    By:
    • Tanaka, Kiyo;
    • Hanai, Nobuhiro;
    • Eba, Junko;
    • Mizusawa, Junki;
    • Asakage, Takahiro;
    • Homma, Akihiro;
    • Kiyota, Naomi;
    • Fukuda, Haruhiko;
    • Hayashi, Ryuichi;
    • Group, Head and Neck Cancer Study Group of the Japan Clinical Oncology
    Publication type:
    Article
    4

    A randomized phase II/III trial of conventional paclitaxel and carboplatin with or without bevacizumab vs dose-dense paclitaxel and carboplatin with or without bevacizumab, in stage IVB, recurrent or persistent cervical carcinoma: Japan Clinical Oncology Group Study (JCOG1311)

    Published in:
    Japanese Journal of Clinical Oncology, 2018, v. 48, n. 12, p. 1096, doi. 10.1093/jjco/hyy137
    By:
    • Ishikawa, Mitsuya;
    • Nakamura, Kenichi;
    • Shibata, Taro;
    • Tanaka, Kiyo;
    • Kitagawa, Ryo;
    • Kobayashi, Hiroaki;
    • Yaegashi, Nobuo;
    • Group, Gynecologic Cancer Study Group of the Japan Clinical Oncology
    Publication type:
    Article
    5
    6
    7
    8

    JJCO Best Reviewer Award.

    Published in:
    Japanese Journal of Clinical Oncology, 2018, v. 48, n. 12, p. 1035, doi. 10.1093/jjco/hyy167
    Publication type:
    Article
    9

    IN THIS ISSUE.

    Published in:
    Japanese Journal of Clinical Oncology, 2018, v. 48, n. 12, p. 1, doi. 10.1093/jjco/hyy163
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17